title: Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
abstract: In a conventional adenovirus (Ad) vector production method using 293 cells, homologous recombination between Ad vector DNA and 293 cell-derived Ad E1 DNA occurs with low efficiency, resulting in the generation of replication-competent adenovirus (RCA). RCA can induce the spread of replication-incompetent Ad vectors, leading to unexpected tissue damage. In order to overcome this problem, we developed an Ad vector production system free of RCA generation by utilizing the Ad packaging size limit of the viral genome. It is well known that up to approximately 105% (37.7 kb) of the wild-type genome (35.9 kb) can be packaged in the Ad virion. We designed the Ad vector genome by insertion of a transgene expression cassette into the E3 region, such that homologous recombination between the Ad vector DNA and 293 cell-derived Ad E1 DNA would produce an Ad vector genome that exceeds in the size of the packaging limit. In accord with our strategy, no RCA generation was observed during the passages when we used the E1 (3.2kb)-deleted Ad vectors containing a more than 3.0-kb transgene expression cassette in the E3 region. In contrast, the E1 (3.2kb)-deleted Ad vectors, which retain 37.7 kb of the viral genome and have an insertion of a 2.1-kb transgene expression cassette in the E3 region, generated RCA, although RCA derived from this Ad vector exceeded the packaging size limit (105.0%). These results suggest that RCA generation can be avoided when the genome size of RCA is more than 108.3% (38.9 kb) of the wild-type Ad genome. This Ad vector production system generates safe, easy, and efficient Ad vector stock for both basic study as well as clinical research.
authors.affiliation: Laboratory of Gene Transfer and Regulation, National Institute of Biomedical Innovation, Osaka, Japan.
authors.forename: Takayuki
authors.initials: T
authors.lastname: Suzuki
authors.forename: Tomomi
authors.initials: T
authors.lastname: Sasaki
authors.forename: Koyori
authors.initials: K
authors.lastname: Yano
authors.forename: Fuminori
authors.initials: F
authors.lastname: Sakurai
authors.forename: Kenji
authors.initials: K
authors.lastname: Kawabata
authors.forename: Masuo
authors.initials: M
authors.lastname: Kondoh
authors.forename: Takao
authors.initials: T
authors.lastname: Hayakawa
authors.forename: Kiyohito
authors.initials: K
authors.lastname: Yagi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Mizuguchi
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D004279:DNA, Viral / Q000235:genetics; D017353:Gene Deletion; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D005827:Genetics, Microbial / Q000379:methods*; D016679:Genome, Viral; D006801:Humans; D019076:Transgenes; D014773:Virology / Q000379:methods*; D019065:Virus Assembly
chemical_list: D004279:DNA, Viral